Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Dige

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Crohn'S & Colitis|December 3, 2013
The lectin pathway of the complement system is downregulated in Crohn's disease patients who respond to anti-TNF-α therapyThomas Damgaard Sandahl, Jens Kelsen, Anders Dige, et al.
Nutrients|April 3, 2021
Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn's Disease during One-Year Follow-UpMia Bendix, Anders Dige, Søren Peter Jørgensen, et al.
Scandinavian Journal of Gastroenterology|September 9, 2016
Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitisKristian Aarslev, Anders Dige, Stinne R Greisen, et al.
Scandinavian Journal of Gastroenterology|May 24, 2025
Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's diseaseMorten Aagaard Nielsen, Mia Bendix, Christian Lodberg Hvas, et al.
Nutrients|December 3, 2020
Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with InfliximabMia Bendix, Anders Dige, Søren Peter Jørgensen, et al.
Diseases of the Colon and Rectum|December 20, 2022
Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Complex Cryptoglandular Anal FistulasHelene R Dalby, Anders Dige, Bodil G Pedersen, et al.
European Journal of Clinical Investigation|April 20, 2016
Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot studyChristian L Hvas, Anders Dige, Mia Bendix, et al.
Gastroenterology|February 18, 2019
Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's DiseaseAnders Dige, Helene Tarri Hougaard, Jørgen Agnholt, et al.
European Journal of Gastroenterology & Hepatology|May 17, 2019
Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatmentLone Larsen, Tine Jess, Asbjørn M Drewes, et al.
BMJ Open|February 28, 2020
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort studyMirabella Zhao, Flemming Bendtsen, Andreas Munk Petersen, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Crohn'S & Colitis|December 3, 2013
The lectin pathway of the complement system is downregulated in Crohn's disease patients who respond to anti-TNF-α therapyThomas Damgaard Sandahl, Jens Kelsen, Anders Dige, et al.
Nutrients|April 3, 2021
Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn's Disease during One-Year Follow-UpMia Bendix, Anders Dige, Søren Peter Jørgensen, et al.
Scandinavian Journal of Gastroenterology|September 9, 2016
Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitisKristian Aarslev, Anders Dige, Stinne R Greisen, et al.
Scandinavian Journal of Gastroenterology|May 24, 2025
Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's diseaseMorten Aagaard Nielsen, Mia Bendix, Christian Lodberg Hvas, et al.
Nutrients|December 3, 2020
Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with InfliximabMia Bendix, Anders Dige, Søren Peter Jørgensen, et al.
Diseases of the Colon and Rectum|December 20, 2022
Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Complex Cryptoglandular Anal FistulasHelene R Dalby, Anders Dige, Bodil G Pedersen, et al.
European Journal of Clinical Investigation|April 20, 2016
Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot studyChristian L Hvas, Anders Dige, Mia Bendix, et al.
Gastroenterology|February 18, 2019
Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's DiseaseAnders Dige, Helene Tarri Hougaard, Jørgen Agnholt, et al.
European Journal of Gastroenterology & Hepatology|May 17, 2019
Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatmentLone Larsen, Tine Jess, Asbjørn M Drewes, et al.
BMJ Open|February 28, 2020
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort studyMirabella Zhao, Flemming Bendtsen, Andreas Munk Petersen, et al.
Pageof 6